Foresea Life Guangzhou General Hospital YiHe International Medical Center, in collaboration with Junchangyi Biotech under the Shenzhen Bay Laboratory Pingshan Translational Medical Center, has jointly established the "Human Microbiome Research Center."
Leveraging the advantages of the internationally leading FMT 3.0 technology—backed by multiple invention patents and safety certifications—the center relies on a top-tier multidisciplinary expert team to ensure rigorous donor screening, microbiota bank management, and transplantation dose optimization. The center now officially launches a Precision-Guided Fecal Microbiota Transplantation Program, dedicated to restoring a healthy gut microbiome for patients with various conditions.
Indications for Fecal Microbiota Transplantation (FMT)
Digestive System Disorders:Diarrhea, Chronic Constipation, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS)
Neurological Disorders:Epilepsy, Parkinson’s Disease, Alzheimer’s Disease
Psychiatric Disorders:Autism Spectrum Disorder (ASD), Major Depressive Disorder (MDD), Attention Deficit Hyperactivity Disorder (ADHD)
Metabolic Disorders:Obesity, Type 2 Diabetes Mellitus (T2DM), Insulin Resistance
Cancer-Related Conditions:Colorectal Cancer, Radiation-Induced Colitis, Immunotherapy-Associated Colitis
Potential Anti-Aging Benefits:FMT may help reduce inflammation, improve metabolism, and enhance immunity, potentially contributing to anti-aging effects. Additionally, it is hypothesized to regulate host genes to slow down the aging process.
Foresea YiHe International Medical Center has launched a comprehensive precision-guided Fecal Microbiota Transplantation (FMT) program package, covering: Preliminary Assessment & Diagnosis, Gut Microbiota Analysis & Report Interpretation, Personalized FMT using big data and advanced technology for precise donor-recipient matching, and Post-Treatment Follow-Up, including targeted health and dietary guidance, as well as ongoing monitoring and re-evaluation By taking a gut-centered approach, this innovative FMT program is designed to address persistent health challenges and provide tailored solutions for patients with various conditions.
Pre-Transplant Phase:Specialist Consultation and Diagnosis, Pre-Treatment Evaluation, Pre-Transplant Gut Microbiota Analysis, Microbiota Report Interpretation
Transplantation Phase:Personalized Medical Intervention Plan, Fecal Microbiota Transplantation (FMT), 21-Day Post-Transplant Dietary and Lifestyle Management
Post-Transplant Phase:Post-Transplant Gut Microbiota Analysis, 3-Month Follow-Up and Health Monitoring
FMT is like a well-orchestrated performance, where each meticulously planned step ensures an optimal outcome. The critical aspects include:
By analyzing stool samples, this test evaluates the gut microbiota composition, dysbiosis levels, and disease risks, providing a standardized and professional report.
Based on microbiota sequencing results, specialists conduct face-to-face consultations and develop a personalized clinical evaluation plan tailored to the patient’s condition. This helps assess overall health and predict potential risks.
Strict Donor Screening: Healthy individuals aged 18-25 undergo rigorous selection to ensure microbiota bank safety. Customized Transplantation Plan: A personalized transplantation approach is designed based on gut microbiota sequencing reports. Advanced Capsule Preparation: Using sterile, anaerobic processing technology, highly concentrated freeze-dried microbiota capsules are produced. Oral Capsule Delivery for FMT: Patients receive microbiota transplants via precisely matched capsules.
If Fecal Microbiota Transplantation (FMT) is a ship sailing toward the "blue ocean" of health, then gut microbiota analysis serves as the "reliable helmsman" ensuring the smooth navigation of this health journey.
Testing evaluates the quantity and balance of gut microbiota, and can even precisely predict gut age and type.
Gene sequencing combined with molecular technology is used for large-scale data analysis, determining gut microbiota health, detecting potential disease risks, and identifying other abnormalities.
Gut microbiota analysis reveals the relative abundance ratio of Firmicutes and Bacteroidetes, which can be used to assess health, microbial imbalance, and potential disease risks.
Gut microbiota composition analysis further refines the assessment of vitamins, trace elements, and amino acids, assisting in the development of a personalized Fecal Microbiota Transplantation (FMT) plan. This approach aims to improve microbial abundance, diversity, and composition, ultimately supporting metabolic regulation.
An imbalanced diet is a significant factor contributing to microbial imbalance. Based on gut microbiota sequencing and analysis, considering disease risks and nutrient deficiencies, personalized dietary recommendations can be provided to enhance nutrient intake with precision.
Gut microbiota testing not only helps specialists gain a comprehensive understanding of a patient’s microbiome functionality but also provides valuable information for FMT planning, safety and health recommendations, as well as post-transplant follow-up.
For inquiries or to schedule a consultation, please contact Foresea YiHe International Medical Center at 020-32996999. Our specialists will promptly arrange a comprehensive assessment and develop a personalized Fecal Microbiota Transplantation (FMT) plan tailored to your specific condition tailored to your needs.
